|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fonofos |
CAS 944-22-9 | ||
C10H15OPS2 |
RTECS TA5950000 | ||
|
Synonyms & Trade Names Dyfonate®; Dyphonate; O-Ethyl-S-phenyl ethylphosphorothioate; Fonophos |
DOT ID & Guide |
||
Exposure
|
NIOSH REL: TWA 0.1 mg/m3 [skin] | ||
| OSHA PEL†: none | |||
| IDLH N.D. See: IDLH INDEX | Conversion 1 ppm = 10.07 mg/m3 | ||
|
Physical Description Light-yellow liquid with an aromatic odor. [insecticide] |
|||
|
MW: 246.3 |
BP: ? |
FRZ: ? |
Sol: 0.001% |
|
VP(77°F): 0.0002 mmHg |
IP: ? |
|
Sp.Gr: 1.15 |
|
Fl.P: >201°F |
UEL: ? |
LEL: ? |
|
| Class IIIB Combustible Liquid: Fl.P. at or above 200°F. | |||
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods NIOSH 5600; OSHA PV2027 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations Not available. |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Nausea, vomiting, abdominal cramps, diarrhea, salivation; headache, dizziness, lassitude (weakness, exhaustion); rhinorrhea (discharge of thin mucus), chest tightness; blurred vision, miosis; cardiac irregularities; muscle fasciculation; dyspnea (breathing difficulty) | |
|
Target Organs
respiratory system, central nervous system, cardiovascular system, blood cholinesterase |
|
| See also: INTRODUCTION See ICSC CARD: 0708 |